Entry before the value curve
Multiple businesses are being built before their scale is reflected in the parent’s valuation. This is the classic window for a growth investor.
Valencia Nutrition Ltd. builds wellness businesses inside its subsidiaries, proves their economics, raises growth capital and lists them separately from the parent. This gallery walks you through each one.

Valencia Nutrition Ltd. (VNL) is a BSE SME listed FMCG conglomerate built to integrate wellness into everyday consumption without changing existing consumption formats and habits.
Anchored in a “Reach-to-Point-of-Consumption” operating philosophy, VNL combines research-driven product development with operational rigour to build scalable, category-relevant businesses across the wellness-oriented FMCG landscape.
VNL is a capital-efficient operating platform, engineered to build businesses of subsidiaries, prove their economics, raise growth capital, and list them separately from the listed parent company.
The company is promoted by Mr. Manish Turakhia, whose leadership has been instrumental in repositioning VNL for its next phase of growth.
He is a seasoned capital market investor with over four decades of experience in equity research and cross-sector analysis spanning financial services, consumer businesses, and emerging growth industries. At VNL, he developed an in-house engineering group with multiple skillsets to develop cutting-edge machinery and value-added products.
Having spent a significant part of his career evaluating business models, consumer demand patterns, and long-term value creation across Indian markets, he now brings an operator’s lens to VNL, underpinned by a research-first mindset and a practical understanding of building durable consumer brands within India’s price-sensitive, scale-driven ecosystem.
His greatest valuation discovery: companies across the globe that manufacture low-ticket consumer items with a repetitive consumption pattern.
Promoter & MDFrom ₹1,500 Cr of planned equity deployment to a projected ₹51,787 Cr 5th-year revenue platform by FY31–32. Switch the chart between equity raise and projected market cap, and hover or tap a bar for that subsidiary’s projections.
Projected figures: forward-looking estimates, not guarantees of future performance. [PLACEHOLDER: legal disclaimer]
₹ Cr, FY31–32 projections · total ₹1,500 Cr
Each subsidiary has its own listing and QIP pathway. Open one for its investor snapshot, financing stage and business documents.
Hover a business to see its brands and products
Multiple businesses are being built before their scale is reflected in the parent’s valuation. This is the classic window for a growth investor.
Exposure to beverages, healthy snacks, automated retail and nutracare gives the Group several independent routes to scale, each with its own listing and QIP pathway.
Production moving in-house assures consistent quality where scale justifies it, lowering the cost architecture and reinvesting the savings into growth.
The documents linked in VNL’s CCPS equity issuance brief, viewable here. Open one to read it in place.
Tap a step to see what happens at that stage.
Inward capital is issued as Cumulative Convertible Preference Shares (CCPS) in each subsidiary, convertible at the end of Year Five.
Simultaneously, the subsidiary is listed by way of demerger from the listed parent, separately on BSE & NSE.
An FPO (in case of Offer for Sale) or QIP (in case all funds go into the company) is planned.
We are committed to delivering a greater RoI over the investment period and beyond.
Contact Manish Turakhia